OLMA
OLMA
US68062P1066
Olema Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
684.23M EUR
1.09B EUR
1.3B EUR
2.03B EUR
Enterprise Value
226.82M EUR
1.05B EUR
1.25B EUR
1.99B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-2.97x
--
--
--
Price to Sales
--
--
--
--
Price to Book
1.59x
2.54x
2.71x
4.25x
EV/Revenue
--
--
--
--
EV/EBITDA
-1.03x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-13.02%
-15.08%
-11.42%
-5.05%
ende